Advertisement
Organisation › Details
Bristol Myers Squibb (BMS) (Group)
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook and Instagram. Celgene and Juno Therapeutics are wholly owned subsidiaries of Bristol-Myers Squibb Company. In certain countries outside the U.S., due to local laws, Celgene and Juno Therapeutics are referred to as, Celgene, a Bristol Myers Squibb company and Juno Therapeutics, a Bristol Myers Squibb company. *
Start | 1989-10-04 merged | |
Industry | pharmaceutical | |
Region | New York, NY | |
Country | United States (USA) | |
Street | 430 East 29th Street 14th Floor | |
City | 10016 New York, NY | |
Tel | +1-212-546-4000 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | H: 10,001 to 50,00 (2018-12-31) |
Currency | USD | |
Annual sales | 22,561,000,000 (revenue, total, consolidated (2018) 2018-12-31) | |
Profit | 4,947,000,000 (2018-12-31) | |
Cash | 6,911,000,000 (2018-12-31) | |
* Document for »About Section«: | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Bristol Myers Squibb (BMS) (Group)
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top